Quantcast
Don't miss
Home / COVID-19 coverage / 2nd COVID-19 vaccine trial paused over unexplained illness

2nd COVID-19 vaccine trial paused over unexplained illness

A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot.

Leave a Reply

Your email address will not be published. Required fields are marked *

*